Phio Long Term Debt Total vs Property Plant Equipment Analysis
PHIO Stock | USD 0.73 0.02 2.67% |
Phio Pharmaceuticals financial indicator trend analysis is much more than just breaking down Phio Pharmaceuticals Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phio Pharmaceuticals Corp is a good investment. Please check the relationship between Phio Pharmaceuticals Long Term Debt Total and its Property Plant Equipment accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Long Term Debt Total vs Property Plant Equipment
Long Term Debt Total vs Property Plant Equipment Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phio Pharmaceuticals Corp Long Term Debt Total account and Property Plant Equipment. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Phio Pharmaceuticals' Long Term Debt Total and Property Plant Equipment is -0.21. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Phio Pharmaceuticals Corp, assuming nothing else is changed. The correlation between historical values of Phio Pharmaceuticals' Long Term Debt Total and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Phio Pharmaceuticals Corp are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Long Term Debt Total i.e., Phio Pharmaceuticals' Long Term Debt Total and Property Plant Equipment go up and down completely randomly.
Correlation Coefficient | -0.21 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Long Term Debt Total
Property Plant Equipment
Most indicators from Phio Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phio Pharmaceuticals Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Phio Pharmaceuticals' Issuance Of Capital Stock is very stable compared to the past year. As of the 2nd of June 2024, Sales General And Administrative To Revenue is likely to grow to 211.86, while Selling General Administrative is likely to drop about 4.2 M.
2023 | 2024 (projected) | Reconciled Depreciation | 187K | 117.1K | Non Recurring | 4.2M | 3.8M |
Phio Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Phio Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phio Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 8.0M | 15.7M | 25.2M | 12.8M | 9.4M | 12.4M | |
Other Current Liab | 27K | 104K | 2.7M | 890K | 942K | 1.1M | |
Total Current Liabilities | 1.9M | 2.2M | 3.1M | 1.8M | 1.6M | 2.2M | |
Total Stockholder Equity | 5.7M | 13.0M | 21.9M | 10.8M | 7.7M | 8.1M | |
Property Plant And Equipment Net | 721K | 557K | 416K | 344K | 39K | 37.1K | |
Net Debt | (6.4M) | (13.6M) | (23.8M) | (11.5M) | (8.5M) | (8.9M) | |
Retained Earnings | (94.8M) | (103.6M) | (116.9M) | (128.4M) | (139.2M) | (132.2M) | |
Accounts Payable | 809K | 728K | 283K | 779K | 657K | 647.1K | |
Cash | 6.9M | 14.2M | 24.1M | 11.8M | 8.5M | 10.8M | |
Non Current Assets Total | 739K | 575K | 443K | 368K | 42K | 39.9K | |
Cash And Short Term Investments | 6.9M | 14.2M | 24.1M | 11.8M | 8.5M | 11.5M | |
Common Stock Shares Outstanding | 38.4K | 382.3K | 1.1M | 1.1M | 2.1M | 2.2M | |
Liabilities And Stockholders Equity | 8.0M | 15.7M | 25.2M | 12.8M | 9.4M | 12.4M | |
Other Current Assets | 316K | 870K | 620K | 615K | 832K | 476.8K | |
Other Stockholder Equity | 100.6M | 116.6M | 138.8M | 139.2M | 137.6M | 88.1M | |
Total Liab | 2.3M | 2.7M | 3.2M | 2.0M | 1.6M | 3.1M | |
Property Plant And Equipment Gross | 721K | 557K | 416K | 344K | 1.2M | 1.2M | |
Total Current Assets | 7.3M | 15.2M | 24.7M | 12.4M | 9.3M | 12.1M | |
Property Plant Equipment | 172K | 210K | 557K | 416K | 478.4K | 268.2K | |
Net Tangible Assets | 13.6M | 5.7M | 13.0M | 21.9M | 25.2M | 26.5M | |
Retained Earnings Total Equity | (78.6M) | (85.9M) | (94.8M) | (103.6M) | (93.3M) | (97.9M) | |
Capital Surpluse | 80.4M | 99.5M | 100.6M | 116.6M | 134.1M | 86.0M | |
Net Invested Capital | 5.7M | 13.2M | 21.9M | 10.8M | 7.7M | 11.8M | |
Net Working Capital | 5.4M | 13.0M | 21.7M | 10.5M | 7.7M | 11.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Phio Stock analysis
When running Phio Pharmaceuticals' price analysis, check to measure Phio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phio Pharmaceuticals is operating at the current time. Most of Phio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Phio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.52) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.